Manual result transcription without verification during data review – remediation failure analysis



Published on 06/01/2026

Further reading: Data Integrity Breach Case Studies

Analysis of Manual Result Transcription Failures During Data Review and Remediation

The pharmaceutical manufacturing landscape is heavily governed by strict regulations designed to ensure product quality and integrity. However, breaches in data integrity can occur, leading to significant regulatory ramifications. In this case study, we will delve into a field scenario where manual result transcription without verification during data review resulted in a substantial deviation. By examining this incident, we aim to equip pharmaceutical professionals with actionable insight into detection, containment, investigation, and subsequent corrective actions.

After reading this article, you will understand how to address similar data integrity breaches effectively while ensuring inspection readiness. You will gain practical knowledge on the steps to take and the evidence required to mitigate risks associated with manual data handling in pharmaceutical environments.

Symptoms/Signals on the Floor or in the Lab

The initial discovery of the

deviation began when Quality Control (QC) personnel noticed an unexpected discrepancy during routine product testing. Specifically, the analytical results recorded for a batch of product X did not align with the expected outcome based on prior trending data. Additionally, a critical review of the batch production records displayed inconsistencies in the complete transcription of results from raw data sheets to the electronic system without appropriate verification steps.

Other symptomatic signals included:

  • Increased inquiries from production teams regarding test results that did not match historical data.
  • Frequent alerts in the quality management system (QMS) related to deviations in trend analyses.
  • Feedback from the data review team regarding potential data entry errors noted in previous batches.

These signals warranted immediate attention to ascertain the extent and nature of the transcription errors, emphasizing the importance of a zero-tolerance policy for data integrity breaches.

Likely Causes

Upon preliminary evaluation, the causes of the transcription error were categorized through the ‘5Ms’ framework: Materials, Method, Machine, Man, Measurement, and Environment.

Category Likely Cause Description
Materials Data Entry Logs Old data sheets with unclear writing contributed to misunderstanding results.
Method Lack of Standard Operating Procedures (SOPs) No established protocol for verification after transcription increases risk.
Machine Manual Entry Systems Reliance on manual input led to human error.
Man Insufficient Training New staff lacked adequate training on data integrity principles.
Measurement Inconsistent Metrics Differences in measuring techniques across laboratories.
Environment High Stress and Time Pressure Increased workload led to rushed data entry.
Pharma Tip:  Uncontrolled spreadsheet calculations during internal audit – remediation failure analysis

Immediate Containment Actions (First 60 Minutes)

On identification of the potential data integrity breach, the following immediate actions were initiated:

  1. Stop any further data entry related to the batch under investigation to prevent additional errors.
  2. Notify the Quality Assurance (QA) team and relevant stakeholders of the suspected deviation.
  3. Segregate the impacted batch and label it as “Under Investigation” to prevent distribution.
  4. Initiate a review of the stored raw data sheets and electronic entries.
  5. Compile a team of cross-functional experts including Quality Control, Quality Assurance, and IT for an urgent investigation.

Documentation of these containment measures should be clearly recorded in the incident report to maintain an audit trail for both internal and regulatory reviews.

Investigation Workflow

To investigate the severity and implications of the transcription errors, a structured workflow was employed, which included:

  • Data Collection: Gather all relevant documentation, including raw data sheets, electronic records, and the batch production records. It’s critical to compile these documents chronologically to identify any trends in the discrepancies.
  • Interviews: Conduct interviews with operators and QC analysts involved in the data entry process to gain insights into potential human factors causing the errors.
  • Review Systems: Examine the electronic data management system settings to ensure that verification features are functioning or, if absent, documented as a gap.

Throughout this stage, continuous communication among the investigation team members is crucial to align findings and focus efforts on common goals.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Several root cause analysis tools can be effectively employed to get to the core of the transcription failures. Here are three notable methods:

5-Why Analysis

This technique involves asking “why” a problem occurs at least five times to drill down to the root cause. It’s particularly useful when the causes appear to cascade from one another.

Fishbone (Ishikawa) Diagram

This visual representation categorizes potential causes into various sections (machinery, processes, man, etc.) and is useful for team brainstorming sessions to clearly define multiple causes simultaneously.

Fault Tree Analysis (FTA)

FTA is a deductive, top-down approach focused on identifying various fault paths leading to a failure. It’s beneficial in complex systems where many interdependent processes exist.

It’s advisable to select tools based on the complexity of the situation and the data available. For singular occurrences, the 5-Why might suffice, while complex systems might benefit from both Fishbone and FTA.

Pharma Tip:  Repeat DI lapses tolerated during data review – remediation failure analysis

CAPA Strategy (Correction, Corrective Action, Preventive Action)

The next essential step is establishing a comprehensive Corrective And Preventive Action (CAPA) plan. The following structures were set during the CAPA meeting:

Correction

Immediately fix the erroneous data entries in the system and reprocess the affected batches. Ensure this correction is documented adequately.

Related Reads

Corrective Action

Implement controls to prevent the recurrence of this issue. This should include:

  • Updating SOPs to incorporate mandatory verification steps in data collection processes.
  • Introducing automated data verification mechanisms wherever feasible to reduce manual input reliance.
  • Enhancing training programs for all personnel involved in data management.

Preventive Action

Introduce scheduled audits and random sampling of data entries to preemptively catch errors before they reach final review stages. Such measures will lead to a robust system of checks that promote accountability in data handling.

Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

A robust control strategy serves as a backbone to maintaining data integrity post-incident. This includes statistical process control (SPC) techniques, regular trending analyses, and rigorous sampling strategies:

  • SPC: Continuous data monitoring can help detect variations from expected results in real-time.
  • Trending Analyses: Historical data trends can highlight anomalies that may indicate deeper systemic issues.
  • Alarms: Automated systems involved in data entry should incorporate alarm features that flag anomalies immediately.
  • Periodic Verification: Regular cross-checks should be mandated as an essential practice, including dual-entry systems when applicable.

Validation / Re-qualification / Change Control Impact (When Needed)

Any changes made to systems or processes as a basis of the CAPA must undergo proper validation and re-qualification:

  • Validation: Confirm that any software or automated systems adopted function as intended to ensure data integrity.
  • Re-qualification: Validate equipment used in the data collection process to ensure it meets all operational requirements.
  • Change Control: Maintain a change control system that documents all alterations made in SOPs, processes, and systems resulting from the CAPA. Evidence of this should be closely monitored through audit trails.

Inspection Readiness: What Evidence to Show

When preparing for regulatory inspections following a data integrity issue, it is critical to have comprehensive evidence demonstrating adherence to GMP guidelines. Recommended documentation includes:

  • Records of Training: Documentation showing training effectiveness will be scrutinized, including attendance records and competency assessments.
  • Incident Reports: Detailed reports articulating the deviation’s nature, steps taken for containment, and resulting CAPA.
  • Batch Records: Clear, complete, and accurate batch production and testing records that reflect adherence to SOPs and understandings of regulatory expectations.
  • Audit Logs: Electronic systems should maintain logs of data entries, verifications, and system changes as evidence of commitment to data integrity.
Pharma Tip:  Audit trail deletion identified during data review – remediation failure analysis

FAQs

What is data integrity in the pharmaceutical industry?

Data integrity refers to the accuracy, consistency, and reliability of data throughout its lifecycle, ensuring that it is maintained and protected against unauthorized alteration.

What can lead to data integrity breaches?

Common causes include human error, insufficient training, lack of oversight, outdated systems, and operational pressures within the organization.

How can organizations prevent data integrity issues?

Implementing robust SOPs, regular training, automated systems, and thorough documentation practices all contribute to minimizing the risk of data integrity breaches.

What actions should be taken once a data integrity issue is discovered?

Immediate containment actions should be initiated, followed by a structured investigation, root cause analysis, and a comprehensive CAPA plan.

Why is root cause analysis important?

Root cause analysis is critical for identifying the underlying issues that led to the breach, which is essential for implementing effective corrective measures to prevent recurrence.

What role does training play in ensuring data integrity?

Proper training ensures that personnel understand the importance of data integrity, operational procedures, and their responsibilities, significantly reducing the likelihood of errors.

How is CAPA linked to data integrity?

CAPA is an essential framework for addressing deviations, ensuring that corrective and preventive measures are documented and implemented effectively to maintain data integrity.

What is the significance of inspection readiness?

Inspection readiness signifies an organization’s commitment to compliance with regulatory requirements, demonstrating that all processes meet standards for data integrity and quality control.

When should a validation process be initiated?

A validation process should be initiated whenever there are changes to systems, processes, or procedures that could impact product quality or data integrity.

How to prepare documentation for regulatory inspections?

All documentation must be organized, readily accessible, and reflect compliance with regulatory standards, including training records, CAPA reports, audit logs, and batch records.

What is Statistical Process Control (SPC) and its importance?

SPC is a method used to monitor and control a process through statistical methods, which helps detect variations early, ensuring quality and compliance.

How often should training programs be updated?

Training programs should be updated regularly, especially after a deviation or when there are changes in processes, systems, or regulations to maintain employee competency.